Trials / Completed
CompletedNCT04743635
CONtrolled Focal Fibrous Band Release Method Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 74 (actual)
- Sponsor
- Revelle Aesthetics, Inc · Industry
- Sex
- Female
- Age
- 21 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
Study to evaluate the safety and effectiveness of the Avéli medical device to reduce the appearance of cellulite.
Detailed description
Multi-center, single-arm clinical study to evaluate the safety and effectiveness of the Avéli device in reducing the appearance of cellulite.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Avéli device | Minimally invasive single procedure with the Avéli device for reduction in the appearance of cellulite in the thighs and buttocks. |
Timeline
- Start date
- 2021-01-07
- Primary completion
- 2021-06-14
- Completion
- 2022-03-04
- First posted
- 2021-02-08
- Last updated
- 2023-06-06
- Results posted
- 2023-06-06
Locations
9 sites across 2 countries: United States, Australia
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04743635. Inclusion in this directory is not an endorsement.